Company intelligence / Profile preview

Voluntis

Paris, Île-de-France, Francevoluntis.com ↗

Ownership: Private
Employees: ~100
Development stage: Other

Overview

Voluntis has developed multiple digital therapeutics that have received 14 regulatory clearances across the US, Europe, and Canada. Their solutions are clinically validated for improving self-management of chronic conditions such as diabetes and cancer. Over 100,000 patients have used their products in real-world settings[1][4][5].

Therapeutic areas: HematologyEndocrinologyOncology
Modalities: Device (specifically, Software as a Medical Device)Non-pharmacological therapy (digital therapeutic interventions)
Industry: Digital Health Medical Devices

Partnerships

Bristol Myers Squibb (co-developing digital therapeutics in oncology)[6]AliveCor (partnership to advance atrial fibrillation management in cancer patients)[1]Collaborations with AstraZeneca on e-Cediranib Olaparib application[6]Multiple global pharmaceutical partners [1][4]

Beyond the preview

Go deeper on Voluntis.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Voluntis.